Association analysis of the GDNF gene with methamphetamine use disorder in a Japanese population

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 35, Issue 5, 2011, Pages 1268-1272

  Yoshimura, Tomoko ^a   Usui, Hinako ^b   Takahashi, Nagahide ^c   Yoshimi, Akira ^b   Saito, Shinichi ^d   Aleksic, Branko ^b,m   Ujike, Hiroshi ^e,l   Inada, Toshiya ^f,l   Yamada, Mitsuhiko ^g,l   Uchimura, Naohisa ^h,l   Iwata, Nakao ^i,l,m   Sora, Ichiro ^j,l   Iyo, Masaomi ^k,l   Ozaki, Norio ^b,l,m  

^a MEIJO UNIVERSITY   (Japan)

^b NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^d Matuzakakousei Hospital   (Japan)

^e OKAYAMA UNIVERSITY   (Japan)

^f SEIWA HOSPITAL   (Japan)

^g NATIONAL INSTITUTE OF MENTAL HEALTH   (Japan)

^h Kurume University Graduate School of Medicine Kurume University Graduate School of Medicine Graduate School Biostatistics   (Japan)

ⁱ FUJITA HEALTH UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^j TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^k CHIBA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^l Japanese Genetics Initiative for Drug Abuse ^*  (Japan)

^m JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

more..

Author keywords

Association study; Dopamine; GDNF; Genetic disorders; Methamphetamine; Single nucleotide polymorphism

Indexed keywords

GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; METHAMPHETAMINE;

ADULT; ALLELE; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DRUG DEPENDENCE; FEMALE; GDNF GENE; GENE FREQUENCY; GENE LOCUS; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; JAPANESE; MAJOR CLINICAL STUDY; MALE; METHAMPHETAMINE DEPENDENCE; SINGLE NUCLEOTIDE POLYMORPHISM;

ALLELES; AMPHETAMINE-RELATED DISORDERS; ASIAN CONTINENTAL ANCESTRY GROUP; DOPAMINE; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR; HUMANS; JAPAN; LINKAGE DISEQUILIBRIUM; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; SEQUENCE TAGGED SITES; SIGNAL TRANSDUCTION;

EID: 79957863625     PISSN: 02785846     EISSN: 18784216     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2011.04.003     Document Type: Article

References (32)

1. Aoyama N., Takahashi N., Kitaichi K., Ishihara R., Saito S., Maeno N., et al. Association between gene polymorphisms of SLC22A3 and methamphetamine use disorder. Alcohol Clin Exp Res 2006, 30(10):1644-1649.
2. Balding D.J. A tutorial on statistical methods for population association studies. Nat Rev Genet 2006, 7(10):781-791.
3. Barrett J.C., Fry B., Maller J., Daly M.J. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005, 21(2):263-265.
4. Boger H.A., Middaugh L.D., Patrick K.S., Ramamoorthy S., Denehy E.D., Zhu H., et al. Long-term consequences of methamphetamine exposure in young adults are exacerbated in glial cell line-derived neurotrophic factor heterozygous mice. J Neurosci 2007, 27(33):8816-8825.
5. Carnicella S., Ron D. GDNF-a potential target to treat addiction. Pharmacol Ther 2009, 122:9-18.
6. Carnicella S., Kharazia V., Jeanblanc J., Janak P.H., Ron D. GDNF is a fast-acting potent inhibitor of alcohol consumption and relapse. Proc Natl Acad Sci USA 2008, 105(23):8114-8119.
7. Dudbridge F. Likelihood-based association analysis for nuclear families and unrelated subjects with missing genotype data. Hum Hered 2008, 66(2):87-98.
8. Elkashef A., Vocci F., Hanson G., White J., Wickes W., Tiihonen J. Pharmacotherapy of methamphetamine addiction: an update. Subst Abus 2008, 29(3):31-49.
9. Freedman R. Schizophrenia. N Engl J Med 2003, 349(18):1738-1749.
10. Ghitza U.E., Zhai H., Wu P., Airavaara M., Shaham Y., Lu L. Role of BDNF and GDNF in drug reward and relapse: a review. Neurosci Biobehav Rev 2010, 35(2):157-171.
11. Green-Sadan T., Kinor N., Roth-Deri I., Geffen-Aricha R., Schindler C.J., Yadid G. Transplantation of glial cell line-derived neurotrophic factor-expressing cells into the striatum and nucleus accumbens attenuates acquisition of cocaine self-administration in rats. Eur J Neurosci 2003, 18(7):2093-2098.
12. Green-Sadan T., Kuttner Y., Lublin-Tennenbaum T., Kinor N., Boguslavsky Y., Margel S., et al. Glial cell line-derived neurotrophic factor-conjugated nanoparticles suppress acquisition of cocaine self-administration in rats. Exp Neurol 2005, 194(1):97-105.
13. Grimm L., Holinski-Feder E., Teodoridis J., Scheffer B., Schindelhauer D., Meitinger T., et al. Analysis of the human GDNF gene reveals an inducible promoter, three exons, a triplet repeat within the 3'-UTR and alternative splice products. Hum Mol Genet 1998, 7(12):1873-1886.
14. Haga H., Yamada R., Ohnishi Y., Nakamura Y., Tanaka T. Gene-based SNP discovery as part of the Japanese Millennium Genome Project: identification of 190,562 genetic variations in the human genome. Single-nucleotide polymorphism. J Hum Genet 2002, 47(11):605-610.
15. Kendler K.S., Gardner C., Jacobson K.C., Neale M.C., Prescott C.A. Genetic and environmental influences on illicit drug use and tobacco use across birth cohorts. Psychol Med 2005, 35(9):1349-1356.
16. Kishi T., Tsunoka T., Ikeda M., Kitajima T., Kawashima K., Okochi T., et al. Serotonin 1A receptor gene is associated with Japanese methamphetamine-induced psychosis patients. Neuropharmacology 2010, 58(2):452-456.
17. Krieglstein K., Suter-Crazzolara C., Unsicker K. Development of mesencephalic dopaminergic neurons and the transforming growth factor-beta superfamily. J Neural Transm Suppl 1995, 46:209-216.
18. Lee K., Kunugi H., Nanko S. Glial cell line-derived neurotrophic factor (GDNF) gene and schizophrenia: polymorphism screening and association analysis. Psychiatry Res 2001, 104(1):11-17.
19. Lichtenstein P., Yip B.H., Bjork C., Pawitan Y., Cannon T.D., Sullivan P.F., et al. Common genetic determinants of schizophrenia and bipolar disorder in Swedish families: a population-based study. Lancet 2009, 373(9659):234-239.
20. Lin L.F., Doherty D.H., Lile J.D., Bektesh S., Collins F. GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons. Science 1993, 260(5111):1130-1132.
21. Messer C.J., Eisch A.J., Carlezon W.A., Whisler K., Shen L., Wolf D.H., et al. Role for GDNF in biochemical and behavioral adaptations to drugs of abuse. Neuron 2000, 26(1):247-257.
22. Michelato A., Bonvicini C., Ventriglia M., Scassellati C., Randazzo R., Bignotti S., et al. 3' UTR (AGG)n repeat of glial cell line-derived neurotrophic factor (GDNF) gene polymorphism in schizophrenia. Neurosci Lett 2003, 357(3):235-237.
23. Morita Y., Ujike H., Tanaka Y., Uchida N., Nomura A., Ohtani K., et al. A nonsynonymous polymorphism in the human fatty acid amide hydrolase gene did not associate with either methamphetamine dependence or schizophrenia. Neurosci Lett 2005, 376(3):182-187.
24. Nakama H., Chang L., Cloak C., Jiang C., Alicata D., Haning W. Association between psychiatric symptoms and craving in methamphetamine users. Am J Addict 2008, 17(5):441-446.
25. Okochi T., Kishi T., Ikeda M., Kitajima T., Kinoshita Y., Kawashima K., et al. Genetic association analysis of NRG1 with methamphetamine-induced psychosis in a Japanese population. Prog Neuropsychopharmacol Biol Psychiatry 2009, 33(5):903-905.
26. Purcell S., Cherny S.S., Sham P.C. Genetic Power Calculator: design of linkage and association genetic mapping studies of complex traits. Bioinformatics 2003, 19(1):149-150.
27. Sato M., Numachi Y., Hamamura T. Relapse of paranoid psychotic state in methamphetamine model of schizophrenia. Schizophr Bull 1992, 18(1):115-122.
28. Wang J., Chen G., Lu B., Wu C.P. GDNF acutely potentiates Ca2+ channels and excitatory synaptic transmission in midbrain dopaminergic neurons. Neurosignals 2003, 12(2):78-88.
29. Yamaguchi-Kabata Y., Nakazono K., Takahashi A., Saito S., Hosono N., Kubo M., et al. Japanese population structure, based on SNP genotypes from 7003 individuals compared to other ethnic groups: effects on population-based association studies. Am J Hum Genet 2008, 83(4):445-456.
30. Yan Y., Yamada K., Niwa M., Nagai T., Nitta A., Nabeshima T. Enduring vulnerability to reinstatement of methamphetamine-seeking behavior in glial-cell-line-derived neurotrophic factor mutant mice. FASEB J 2007, 21(9):1994-2004.
31. Yang F., Feng L., Zheng F., Johnson S.W., Du J., Shen L., et al. GDNF acutely modulates excitability and A-type K(+) channels in midbrain dopaminergic neurons. Nat Neurosci 2001, 4(11):1071-1078.
32. Yui K., Ikemoto S., Ishiguro T., Goto K. Studies of amphetamine or methamphetamine psychosis in Japan: relation of methamphetamine psychosis to schizophrenia. Ann NY Acad Sci 2000, 914:1-12.